beta 2-Microglobulin clearance as measured by radioimmunoassay

Area of Science:

• Biochemistry
• Immunology
• Clinical Chemistry

Background:

• Beta 2-microglobulin (beta 2 mu) is a protein found on the surface of most nucleated cells.
• Elevated levels of beta 2 mu can indicate kidney disease or rejection of a transplanted organ.
• Accurate measurement of beta 2 mu is crucial for patient management.

Purpose of the Study:

• To develop and validate a radioimmunoassay (RIA) for quantifying beta 2-microglobulin (beta 2 mu) in human serum and urine.
• To assess the utility of the RIA in distinguishing between normal individuals and renal allograft recipients.
• To correlate beta 2 mu levels with the severity of allograft rejection.

Main Methods:

• A radioimmunoassay was developed using 125I-labeled beta 2 mu and a rabbit antiserum.
• Samples were incubated, and phases were separated using the double-antibody technique.
• Assay validation included precision, accuracy, specificity, and parallelism testing.

Main Results:

• The RIA demonstrated linearity in the range of 2 to 64 ng, with an assay sensitivity of 2.4 ng.
• In normal individuals, serum beta 2 mu ranged from 1.1 to 2.3 mg/L and urine from 40 to 360 micrograms/24 h.
• In renal allograft recipients, serum beta 2 mu ranged from 3.9 to 15.6 mg/L and urine from 7.2 to 611 mg/24 h, correlating with rejection severity.

Conclusions:

• The developed radioimmunoassay provides a sensitive and reliable method for measuring beta 2-microglobulin in serum and urine.
• Beta 2-microglobulin levels and clearance are significantly altered in renal allograft recipients.
• This assay can serve as a valuable tool for monitoring renal allograft status and rejection severity.